New York State Common Retirement Fund Has $95.75 Million Stock Position in Colgate-Palmolive Company (NYSE:CL)

New York State Common Retirement Fund trimmed its position in Colgate-Palmolive Company (NYSE:CL - Free Report) by 10.4% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 1,021,848 shares of the company's stock after selling 119,047 shares during the quarter. New York State Common Retirement Fund owned about 0.13% of Colgate-Palmolive worth $95,747,000 as of its most recent SEC filing.

Several other hedge funds also recently bought and sold shares of the stock. Norges Bank purchased a new position in shares of Colgate-Palmolive in the 4th quarter valued at about $912,375,000. Deutsche Bank AG boosted its position in Colgate-Palmolive by 35.6% during the fourth quarter. Deutsche Bank AG now owns 6,922,994 shares of the company's stock worth $629,369,000 after acquiring an additional 1,816,865 shares during the last quarter. Castlekeep Investment Advisors LLC purchased a new stake in Colgate-Palmolive in the fourth quarter valued at approximately $111,738,000. Renaissance Technologies LLC increased its position in Colgate-Palmolive by 70.2% during the 4th quarter. Renaissance Technologies LLC now owns 2,808,110 shares of the company's stock worth $255,285,000 after purchasing an additional 1,158,060 shares in the last quarter. Finally, GAMMA Investing LLC boosted its position in shares of Colgate-Palmolive by 10,601.7% in the first quarter. GAMMA Investing LLC now owns 1,105,379 shares of the company's stock worth $103,574,000 after buying an additional 1,095,050 shares during the period. Hedge funds and other institutional investors own 80.41% of the company's stock.

Colgate-Palmolive Trading Down 0.8%

Colgate-Palmolive stock traded down $0.69 during trading hours on Monday, reaching $88.89. 3,648,273 shares of the company's stock traded hands, compared to its average volume of 5,334,243. The company has a debt-to-equity ratio of 8.96, a quick ratio of 0.54 and a current ratio of 0.85. The firm has a market capitalization of $72.04 billion, a price-to-earnings ratio of 25.11, a PEG ratio of 4.74 and a beta of 0.37. The firm's 50 day moving average is $90.63 and its 200-day moving average is $90.49. Colgate-Palmolive Company has a fifty-two week low of $85.32 and a fifty-two week high of $109.30.

Colgate-Palmolive (NYSE:CL - Get Free Report) last announced its earnings results on Friday, April 25th. The company reported $0.91 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.86 by $0.05. The business had revenue of $4.91 billion for the quarter, compared to analyst estimates of $4.92 billion. Colgate-Palmolive had a return on equity of 461.04% and a net margin of 14.52%. Colgate-Palmolive's revenue for the quarter was down 3.0% compared to the same quarter last year. During the same quarter last year, the firm earned $0.86 EPS. On average, analysts predict that Colgate-Palmolive Company will post 3.75 earnings per share for the current year.

Colgate-Palmolive announced that its Board of Directors has authorized a share buyback program on Thursday, March 20th that permits the company to buyback $5.00 billion in shares. This buyback authorization permits the company to reacquire up to 6.8% of its shares through open market purchases. Shares buyback programs are generally an indication that the company's management believes its stock is undervalued.

Colgate-Palmolive Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, August 15th. Investors of record on Friday, July 18th will be issued a dividend of $0.52 per share. The ex-dividend date is Friday, July 18th. This represents a $2.08 annualized dividend and a yield of 2.34%. Colgate-Palmolive's payout ratio is currently 58.76%.

Analyst Upgrades and Downgrades

A number of research firms recently commented on CL. Barclays decreased their price target on Colgate-Palmolive from $89.00 to $86.00 and set an "equal weight" rating for the company in a research note on Friday, April 11th. UBS Group lifted their target price on Colgate-Palmolive from $105.00 to $109.00 and gave the stock a "buy" rating in a report on Thursday, April 17th. Wall Street Zen lowered Colgate-Palmolive from a "buy" rating to a "hold" rating in a research report on Wednesday, May 7th. JPMorgan Chase & Co. boosted their target price on shares of Colgate-Palmolive from $95.00 to $103.00 and gave the stock an "overweight" rating in a research report on Monday, April 28th. Finally, Wells Fargo & Company lifted their price objective on Colgate-Palmolive from $83.00 to $88.00 and gave the stock an "underweight" rating in a research note on Wednesday, April 2nd. One research analyst has rated the stock with a sell rating, ten have given a hold rating and eight have given a buy rating to the company's stock. According to data from MarketBeat, the stock presently has a consensus rating of "Hold" and a consensus price target of $101.13.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.